ERIK BLACKWOOD

Assistant Professor

Nutrition & Integrative Physiology

  • Assistant Professor
    Nutrition & Integrative Physiology
  • Adjunct Assistant Professor
    Biomedical Engineering

RESEARCH INTERESTS

Heart disease is the leading cause of mortality in the US and is often preceded by pathological cardiac hypertrophy due to chronic hypertension and sustained increases in cardiac afterload. While initially an adaptive response to maintain cardiac output and systemic blood supply, pathological cardiac hypertrophy eventually leads to a decompensated state of heart failure (HF). The initial adaptive aspect of hypertrophic growth requires increases in protein synthesis, which must be balanced by adequate protein folding, and degradation of misfolded, potentially toxic proteins. Without this balance, cardiac myocytes cannot maintain protein homeostasis, or proteostasis, which threatens functional cellular integrity and viability. The Blackwood laboratory is focused on elucidating novel mechanisms whereby proteostasis machinery in the heart protects against chronic systemic diseases, such as HF and global metabolic syndrome, translating these discoveries into novel therapeutics, and evaluating their efficacy in preclinical models of HF. Specifically, we have three directives guiding our research program: (1) Elucidate novel mechanisms for heart-directed inter-organ communication during metabolic syndrome (i.e. Axes of Cardiometabolic Health); (2) Determine mechanisms contributing to atrial dysfunction and remodeling during HF; and (3) Determine the contributions of resident cardiac fibroblasts to the pathogenesis of HF.

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    SNAP23 IS A NOVEL REGULATOR OF AUTOPHAGY IN CARDIAC MYOCYTES
    1 Aug 2026 - 31 Jul 2027
  • EXTERNAL GRANT OR CONTRACT
    ROLES FOR SGK1 IN REGULATING A HEART-LIVER AXIS IN CARDIOMETABOLIC HFPEF
    1 Jul 2026 - 30 Jun 2027
  • EXTERNAL GRANT OR CONTRACT
    SGK1: A NOVEL TARGET FOR ATRIAL MYOPATHY IN HFPEF
    1 Jul 2026 - 30 Jun 2030
  • EXTERNAL GRANT OR CONTRACT
    NOVEL ROLES FOR IRE1 IN REGULATING CARDIAC FIBROSIS
    1 Sep 2025 - 30 Jun 2029
  • EXTERNAL GRANT OR CONTRACT
    ROLES FOR SGK1 IN CARDIOMETABOLIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
    1 Sep 2025 - 31 Jul 2026
  • EXTERNAL GRANT OR CONTRACT
    ROLES FOR SGK1 IN REGULATING A HEART-LIVER AXIS IN CARDIOMETABOLIC HFPEF
    NORA ECCLES TREADWELL FOUNDATION1 Jul 2025 - 30 Jun 2026
    NORA ECCLES TREADWELL FOUNDATION
  • EXTERNAL GRANT OR CONTRACT
    ROLES FOR SGK1 IN REGULATING A HEART-LIVER AXIS IN CARDIOMETABOLIC HFPEF
    NORA ECCLES TREADWELL FOUNDATION1 Jan 2025 - 30 Jun 2025
    NORA ECCLES TREADWELL FOUNDATION
  • EXTERNAL GRANT OR CONTRACT
    ROLES FOR SGK1 IN CARDIOMETABOLIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
    NIH NATIONAL HEART LUNG & BLOOD INST26 Sep 2024 - 31 Aug 2025
    NIH NATIONAL HEART LUNG & BLOOD INST